期刊文献+

MMP-2、MMP-14及VEGF-C在结肠癌组织中的表达及其临床意义 被引量:13

The expressions of MMP-2,MMP-14 and VEGF-C in colon cancer and their clinical significance
原文传递
导出
摘要 分析基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-14(MMP-14)及血管内皮生长因子-C(VEGF-C)在结肠癌中的表达及其与肿瘤临床特征的关系,探讨三者在结肠癌发生发展中的作用及临床意义。采用免疫组织化学方法检测30例结肠癌患者的癌组织及对应癌旁正常结肠组织中MMP-2、MMP-14及VEGF-C的表达情况,分析三者的表达水平与患者性别、年龄、组织学分级、Dukes分期、肿瘤大小、淋巴结转移等临床病理参数之间的相关性。结果显示:1 30例结肠癌组织中MMP-2、MMP-14及VEGF-C的阳性表达率分别为73.3%、80%和66.7%,而在癌旁正常结肠组织中的阳性表达率分别为10%、13.3%和16.7%,两组比较差异均有统计学意义(P<0.05)。2 MMP-2、MMP-14及VEGF-C的表达水平与肿瘤大小、Dukes分期和淋巴结转移有关(P<0.05),而与患者性别、年龄及组织学分级无明显相关性(P>0.05)。3MMP-2、MMP-14及VEGF-C三者两两间表达均相关(P<0.05)。4 30例结肠患者的癌组织中有16例共同高表达MMP-2、MMP-14及VEGF-C,与Dukes分期、病理分级和淋巴结转移有关(P<0.05)。 To investigate the role of MMP-2, MMP-14 and VEGF-C in colon cancer and its significance in colon cancer, we examine the expression of MMP-2, MMP-14 and VEGF-C by immunohistochemistry of 30 patients with colon carcinoma. The relationship between the expression of MMP-2, MMP-14 and VEGF-C and clinicopathological features including sex, age, tumor size, Dukes stage, pathological grade, and lymph node metastasis were examined. The positive rate of MMP-2, MMP-14, and VEGF-Cin the colon cancer tissues was 73.3%, 80%, and 66.7% respectively, while the positive rate of MMP-2, MMP-14, and VEGF-Cin the 30 normal colonic tissues were 10 %, 13.3 %, and 16.7 % respectively, and the differences were statistically significant(P〈0.05). The expression of MMP-2, MMP-14, and VEGF-C related to tumor size, Dukes stages and lymph node metastasis(P〈0. 05), but were unrelated to sex, age and histological grade(P〉0. 05). Between MMP-2, MMP-14 and VEGF-C were related one to another (P〈0.05). In 16 colon cancer specimens which showed high co-expression of MMP-2, MMP-14, and VEGF-C, the expression of these three factors were associated with Dukes stage, pathological grade and lymph node metastasis(P〈0.05).
出处 《现代免疫学》 CAS CSCD 北大核心 2016年第1期21-26,共6页 Current Immunology
基金 国家自然科学基金资助(81201905) 江苏省卫生计生委研究项目(YG201406) 留学回国人员科研启动基金(第50批)
关键词 结肠癌 基质金属蛋白酶-2 基质金属蛋白酶-14 血管内皮生长因子-C 免疫组织化学 Colon cancer MMP-2 MMP-14 VEGF-C immunohistochemistry
  • 相关文献

参考文献5

二级参考文献78

  • 1罗景玉,杨长征,李道堂,张百江.非小细胞肺癌组织中VEGFR-3的表达及临床意义[J].中华肿瘤防治杂志,2006,13(15):1178-1179. 被引量:19
  • 2张太平,赵玉沛.胰腺癌基因治疗的现状与展望[J].中华肝胆外科杂志,2007,13(3):148-151. 被引量:7
  • 3Andren-Sandberg A, Neoptolemos JP. Resection for pancreatic cancer in the new millennium[J]. Pancreatology, 2002(5) :431 -439.
  • 4Laird DW, Fistouris P, Batist G, et al. Deficiency of con nexin43 gap junctions is an independent marker for breast tumors[J]. Cancer Res,1999,59(16) :4104-4110.
  • 5Kitadai Y, Amioka T, Haruma K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas[J]. Int J Cancer,2001,93(5) :662-666.
  • 6Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis[J]. J Bioehem, 2002,132(3):359-371.
  • 7Kato M,Shinozawa T,Kato S,et al. Increased midkine expression in intrahepatic cholangiocarcinoma:immunohistochemical and in situ hybridization analyses[J]. Liver, 2000,20(3) :216-221.
  • 8Kadomatsu K,Muramatsu T. Midkine and pleiotrophin in neural development and cancer[J]. Cancer Lett, 2004,204 (2):127- 143.
  • 9Moon HS, Park WI, Sung SH, et al. Immunohistochemical and quantitative competitive PCR analyses of midkine and pleiotrophin expression in cervical cancer[J]. Gynecol Oncol,2003,88(3) :289- 297.
  • 10Ikematsu S,Okamoto K, Yoshida Y, et al. High levels of urinary midkine in various cancer patients[J]. Biochem Biophys Res Commun, 2003,306 (2) : 329- 332.

共引文献75

同被引文献111

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部